Epinoma Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 18

Epinoma General Information

Description

Developer of an epigenetic blood test technology designed to detect early disease recurrence in cancer patients. The company's technology shows early signs of cancer and neurodegenerative diseases, which replaces traditional methods such as CT imaging and protein markers, with a CRISPR-based liquid blood test to create more effective patient stratification strategies in clinical settings, enabling oncologists to receive assistance in clinical decision-making for late-stage colorectal cancer patients.

Contact Information

Website
www.epinoma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 930 Brittan Avenue
  • San Carlos, CA 94070
  • United States
+1 (925)
Primary Industry
Diagnostic Equipment
Corporate Office
  • 930 Brittan Avenue
  • San Carlos, CA 94070
  • United States
+1 (925)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Epinoma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 01-May-2022 Completed Startup
4. Early Stage VC 21-Oct-2021 Completed Startup
3. Accelerator/Incubator 01-Jun-2021 Completed Startup
2. Accelerator/Incubator 01-Jan-2021 $125K $125K Completed Startup
1. Accelerator/Incubator 01-Jan-2020 Completed Startup
To view Epinoma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Epinoma Patents

Epinoma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026198471-A1 Methods for amplification and detection of modified nucleic acids Pending 15-Mar-2025

Epinoma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Epinoma Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Asymmetry Ventures Venture Capital Minority
Gaingels Venture Capital Minority
LoftyInc Capital Management Venture Capital Minority
Surf Club Ventures Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 18 investors. Get the full list »

Epinoma FAQs

  • When was Epinoma founded?

    Epinoma was founded in 2020.

  • Where is Epinoma headquartered?

    Epinoma is headquartered in San Carlos, CA.

  • What is the size of Epinoma?

    Epinoma has 5 total employees.

  • What industry is Epinoma in?

    Epinoma’s primary industry is Diagnostic Equipment.

  • Is Epinoma a private or public company?

    Epinoma is a Private company.

  • What is Epinoma’s current revenue?

    The current revenue for Epinoma is .

  • How much funding has Epinoma raised over time?

    Epinoma has raised $125K.

  • Who are Epinoma’s investors?

    Asymmetry Ventures, Gaingels, LoftyInc Capital Management, Surf Club Ventures, and are 5 of 18 investors who have invested in Epinoma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process